255 related articles for article (PubMed ID: 21566453)
21. Is S-1 a potential game changer in adjuvant therapy of pancreatic cancer?
Chaulagain CP; Rothschild J; Saif MW
JOP; 2013 Jul; 14(4):329-33. PubMed ID: 23846920
[TBL] [Abstract][Full Text] [Related]
22. [A case of pancreatic acinar cell carcinoma with a giant liver metastasis successfully treated with combination of gemcitabine and peroral S-1].
Nishimizu T; Minemura M; Kajiura S; Tokimitsu Y; Itaya Y; Yamawaki H; Kawai K; Tajiri K; Nakayama Y; Hosokawa A; Takahara T; Yasumura S; Shimizu S; Fukuoka J; Ishizawa S; Sawasaki T; Yanagisawa A; Sugiyama T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):309-12. PubMed ID: 21368502
[TBL] [Abstract][Full Text] [Related]
23. Curative surgical treatment after preoperative chemotherapy for primarily inoperable locally advanced pancreatic carcinoma: report of a case.
Okada K; Imaizumi T; Yazawa N; Matsuyama M; Dowaki S; Tobita K; Hirabayashi K; Makuuchi H
Tokai J Exp Clin Med; 2009 Jul; 34(2):53-7. PubMed ID: 21318999
[TBL] [Abstract][Full Text] [Related]
24. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.
Morimoto Y; Takeuchi O; Takizawa A; Yoneyama H; Asanuma F; Suzuki Y; Atsuda K; Yamada Y
Anticancer Drugs; 2012 Jun; 23(5):505-14. PubMed ID: 22334000
[TBL] [Abstract][Full Text] [Related]
25. [Usefulness of S-1/gemcitabine combination therapy for advanced pancreatic cancer].
Hara T; Nagata M; Yamashita Y; Fujimoto K; Muraki Y; Yasuda Y; Kurahashi T
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1233-7. PubMed ID: 18633271
[TBL] [Abstract][Full Text] [Related]
26. [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1].
Kametaka H; Makino H; Fukada T; Seike K; Koyama T; Hasegawa A
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1641-3. PubMed ID: 26805123
[TBL] [Abstract][Full Text] [Related]
27. [Adjuvant Surgery for Initially Unresectable Locally Advanced Pancreatic Cancer following Gemcitabine and S-1 Chemotherapy--A Case Report].
Tono T; Kawasaki Y; Hashimoto M; Ikeda Y; Senba H; Okubo Y; Katayama T; Ishii T; Shinozaki K; Hayashi H; Yasuda S; Ohtsuru M
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2373-5. PubMed ID: 26805368
[TBL] [Abstract][Full Text] [Related]
28. [Long-Term Survival Due to Combination Therapy in a Patient with Locally Advanced Body-Tail Pancreatic Cancer].
Ueda N; Fujii Y; Miura S; Fujita J; Tomita Y; Ohnishi T; Fujita H; Kinami S; Omote K; Nakano Y; Kosaka T; Motoo Y
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1373-1375. PubMed ID: 29394638
[TBL] [Abstract][Full Text] [Related]
29. [A case of pancreatic cancer with distant metastasis successfully resected after neoadjuvant chemotherapy with a combination of S-1 and gemcitabine].
Maeda T; Tsuchiya M; Ishii J; Koda T; Kubota Y; Katagiri T; Tamura A; Otsuka Y; Shibuya K; Kaneko H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2184-6. PubMed ID: 25731464
[TBL] [Abstract][Full Text] [Related]
30. Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer.
Nakata B; Amano R; Nakao S; Tamura T; Shinto O; Hirakawa T; Okita Y; Yamada N; Hirakawa K
J Exp Clin Cancer Res; 2010 Feb; 29(1):15. PubMed ID: 20181235
[TBL] [Abstract][Full Text] [Related]
31. [Treatments of pancreatic cancer from the standpoint of medical oncology].
Furuse J; Ishii H; Nakachi K; Suzuki E; Shimizu S
Gan To Kagaku Ryoho; 2007 Jul; 34(7):997-1001. PubMed ID: 17637534
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of Gemcitabine and S-1 for Patients with Advanced Pancreatic Cancer.
Cheng YJ; Meng CT; Shao YJ; Li NN; Zhou N; Yan XY; Gao X; Zhou JF; Bai CM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):562-567. PubMed ID: 28877836
[TBL] [Abstract][Full Text] [Related]
33. [A case of abdominal wall metastasis from pancreatic cancer].
Kameda R; Ueno M; Kobayashi S; Miyagawa K; Okawa S; Morinaga S
Gan To Kagaku Ryoho; 2010 Jun; 37(6):1149-52. PubMed ID: 20567126
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcome of gemcitabine/S-1 combination therapy for advanced pancreatic cancer.
Yamauchi J; Kanai M; Matsumoto S; Nishimura T; Yazumi S; Kami K; Kawaguchi Y; Yasuda H; Kitano T; Misawa A; Ishiguro H; Yoshikawa K; Yanagihara K; Fukushima M; Doi R; Chiba T
Pancreas; 2008 Apr; 36(3):327-8. PubMed ID: 18362852
[No Abstract] [Full Text] [Related]
35. [Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].
Sato Y; Tsuchiya Y; Aizawa M; Nomura T; Nashimoto A
Gan To Kagaku Ryoho; 2014 Sep; 41(9):1151-4. PubMed ID: 25248901
[TBL] [Abstract][Full Text] [Related]
36. Retrospective analysis of fixed dose rate infusion of gemcitabine and S-1 combination therapy (FGS) as salvage chemotherapy in patients with gemcitabine-refractory advanced pancreatic cancer: inflammation-based prognostic score predicts survival.
Kasuga A; Okano N; Naruge D; Kitamura H; Takasu A; Nagashima F; Furuse J
Cancer Chemother Pharmacol; 2015 Mar; 75(3):457-64. PubMed ID: 25547407
[TBL] [Abstract][Full Text] [Related]
37. Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study.
Togawa A; Yoshitomi H; Ito H; Kimura F; Shimizu H; Ohtsuka M; Yoshidome H; Kato A; Sawada S; Miyazaki M
Int J Clin Oncol; 2007 Aug; 12(4):268-73. PubMed ID: 17701005
[TBL] [Abstract][Full Text] [Related]
38. [A case of curatively resected locally advanced cancer of the pancreatic body treated by distal pancreatectomy with en bloc celiac axis resection after neoadjuvant chemotherapy].
Okada T; Sakurai N; Yamamoto K; Motoi F; Kakizaki Y; Tamura G; Unno M; Iizawa H
Gan To Kagaku Ryoho; 2012 Jan; 39(1):135-7. PubMed ID: 22241369
[TBL] [Abstract][Full Text] [Related]
39. [A long-term survival case of unresectable malignant pancreatic endocrine tumor successfully treated with systemic chemotherapy].
Masuda T; Kuwahara A
Gan To Kagaku Ryoho; 2008 May; 35(5):833-5. PubMed ID: 18487924
[TBL] [Abstract][Full Text] [Related]
40. [A partial response to S-1 as second-line chemotherapy in a patient with unresectable pancreatic cancer].
Egawa T; Ohashi M; Ito Y; Mihara K; Takahashi T; Hayashi S; Nagashima A
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2422-4. PubMed ID: 20037443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
